The present invention relates novel furan based amine cross-linkers with improved thermomechanical and water barrier properties. The novelty of this invention is the use of aromatic, and hydrophobic aliphatic aldehydes to bridge two furfuryl amines, which yields a diamine or tetra amines with a significantly enhanced hydrophobic character. These diamine cross-linkers exhibit enhanced water barrier properties and thermomechanical properties when cured with both commercial and synthetic epoxies.

The present invention relates novel furan based amine cross-linkers with improved thermomechanical and water barrier properties. The novelty of this invention is the use of aromatic, and hydrophobic aliphatic aldehydes to bridge two furfuryl amines, which yields a diamine or tetra amines with a significantly enhanced hydrophobic character. These diamine cross-linkers exhibit enhanced water barrier properties and thermomechanical properties when cured with both commercial and synthetic epoxies.

The present disclosure provides a low-molecular mass organic gellant and a preparation method and use thereof, belonging to the technical field of gelled fuels. The low-molecular mass organic gellant has a cyclopropane structure. The cyclopropane structure belongs to a high-tension structure, which endows the gellant with excellent gel properties; in addition, the high-tension cyclopropane structure is also capable of greatly improving a combustion performance of the gellant, shortening an ignition delay time of the fuel, and promoting combustion. Moreover, multiple hydroxyl groups contained in the low-molecular mass organic gellant is capable of effectively forming a gel through hydrogen bonding; therefore, the gellant has excellent gel and shear thinning properties for high-energy density fuel and energetic nanofluid fuel, with a critical gellant concentration of not greater than 1% when forming a stable gel.

The present disclosure provides a low-molecular mass organic gellant and a preparation method and use thereof, belonging to the technical field of gelled fuels. The low-molecular mass organic gellant has a cyclopropane structure. The cyclopropane structure belongs to a high-tension structure, which endows the gellant with excellent gel properties; in addition, the high-tension cyclopropane structure is also capable of greatly improving a combustion performance of the gellant, shortening an ignition delay time of the fuel, and promoting combustion. Moreover, multiple hydroxyl groups contained in the low-molecular mass organic gellant is capable of effectively forming a gel through hydrogen bonding; therefore, the gellant has excellent gel and shear thinning properties for high-energy density fuel and energetic nanofluid fuel, with a critical gellant concentration of not greater than 1% when forming a stable gel.

Compounds according to formula (I), where R is as defined herein, have anti-cancer properties.

Disclosed is a compound of formula 1, or a pharmaceutically acceptable salt thereof, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.7′, R.sup.8, R.sup.9, R.sup.10, R.sup.11, R.sup.12 and R.sup.13 are as disclosed herein. Also, disclosed is a process for the preparation of the compound of formula 1, or a pharmaceutically acceptable salt thereof, and intermediates used therein. The compound of formula 1 can be used in the preparation of halichondrin analogs, such as Eribulin; and a process for its preparation from the compound of formula 1 is also disclosed. ##STR00001##

Disclosed is a compound of formula 1, or a pharmaceutically acceptable salt thereof, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.7′, R.sup.8, R.sup.9, R.sup.10, R.sup.11, R.sup.12 and R.sup.13 are as disclosed herein. Also, disclosed is a process for the preparation of the compound of formula 1, or a pharmaceutically acceptable salt thereof, and intermediates used therein. The compound of formula 1 can be used in the preparation of halichondrin analogs, such as Eribulin; and a process for its preparation from the compound of formula 1 is also disclosed. ##STR00001##

Near infrared and shortwave infrared dyes can have polymethine structures.

Provided herein are compounds of formula (I) and compositions containing the compounds. The compounds and compositions are useful in the methods of treating, amelioration or prophylaxix of diseases associated with Nrf2/NF-.sub.κB pathways. The diseases associated include, but are not limited to a fibrotic disease such as lung fibrosis, liver fibrosis, kidney fibrosis, and scleroderma, or a neurodegenerative disease, such as multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, and Alzheimer's disease, and sickle cell disease.

##STR00001##

Provided herein are compounds of formula (I) and compositions containing the compounds. The compounds and compositions are useful in the methods of treating, amelioration or prophylaxix of diseases associated with Nrf2/NF-.sub.κB pathways. The diseases associated include, but are not limited to a fibrotic disease such as lung fibrosis, liver fibrosis, kidney fibrosis, and scleroderma, or a neurodegenerative disease, such as multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, and Alzheimer's disease, and sickle cell disease.

##STR00001##